Phagocyte

Respiratory solutions

How can we help people breathe easier?

Breathing problems affect people in many different ways and can lead to a variety of health issues, such as chronic sinusitis, allergies and asthma. Symptoms can include runny or congested nose; red, itchy and swollen eyes; chest congestion; coughing and wheezing – as well as more serious issues such as laboured breathing. GSK is the number one supplier of over-the-counter respiratory medicines worldwide, with a range of trusted brands including cold and flu remedies, nasal decongestants, allergy relief treatments and smoking cessation aids. By collaborating with other innovators in respiratory treatments, we hope to provide more sufferers with improved comfort and relief.

Our current needs - can you help?

Digital health platforms

We're interested in connected devices that help consumers manage their respiratory conditions. This could relate to diagnostics, medication compliance or symptom tracking for our multi-symptom, Allergy, Decongestion and Smokers’ Health franchises.

Differentiated oral dosage forms

We're seeking differentiated oral dosage forms for our Multi-symptom, Allergy and Smokers’ Health franchises. This could deliver greater efficacy or enhanced user experience. Minimum data requirement = proof of concept.

Nasal spray delivery

We are interested in innovation related to delivery of OTC medicines into the nasal cavity for our Allergy and Decongestion franchise.  This innovation may deliver superior efficacy or enhanced user experience due to unique ingredients/formulations or device design. Minimum data requirement = proof

Next generation nicotine replacement transdermal technology

We are interested in innovative transdermal patch, topical, or device technologies that can provide superior nicotine delivery compared to currently marketed transdermal nicotine delivery patches.

BARRIER-FORMING PRODUCTS

We are seeking products that form a barrier (physical, chemical or otherwise) that maintains the health of the upper respiratory tract (nasal area and throat) with secondary interest in the lower airways. Minimum data requirement = proof of concept.

 

Together with The Cleaning Breathing Institute

ANTIOXIDANT/ANTI-INFLAMMATORY

We are interested in nonprescription healthcare products that are focused on antioxidant/anti-inflammatory products that combat the reactive oxidative species (ROS), free radicals and/or inflammatory mediators caused by exposure to air pollution. These products would maintain or restore the health of the upper respiratory tract (nasal area and throat) with secondary interest in the lower airways. Minimum data requirement = proof of concept.

 

Together with The Cleaning Breathing Institute

DIGITAL

We are interested in connected devices that help consumers manage their respiratory health and the impact of air pollution. Areas of interest broadly include estimation of pollution exposure and symptom tracking. Minimum data requirement = proof of concept.

 

Together with The Cleaning Breathing Institute

Let’s put our minds together

Let’s get started. Join our community and discover how we can accelerate your ideas together